Related Experiment Video
Updated: May 30, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Multivariate contaminated normal linear mixed models applied to Alzheimer's disease study with censored and missing
Tsung-I Lin1,2, Wan-Lun Wang3
1Institute of Statistics, National Chung Hsing University, Taichung, Taiwan.
Abstract:
The article proposes a robust approach to jointly modeling multiple repeated clinical measures with intricate features. More specifically, we aim to expand the scope of the multivariate linear mixed model by using the multivariate contaminated normal distribution. The proposed model, called the multivariate contaminated normal linear mixed model with censored and missing responses (MCNLMM-CM), is designed to handle minor outliers effectively, while simultaneously accommodating censored measurements and intermittent missing responses. An expectation conditional maximization either algorithm is developed to estimate the parameters of the proposed model in situations involving missing at random responses. We also provide techniques for approximating the asymptotic standard errors of the parameters, recovering censored data, imputing missing values, and identifying outliers. A simulation study is conducted to evaluate the finite-sample properties of the parameter estimators and demonstrate the superior performance of the proposed model compared to existing models. The proposed methodology is inspired by and applied to data from the Alzheimer's disease neuroimaging initiative cohort study, which involves longitudinal clinical measurements of patients with mild cognitive impairment.
Insights
This study introduces a new statistical model to effectively analyze complex longitudinal clinical data, even with outliers, missing, or censored values. The multivariate contaminated normal linear mixed model (MCNLMM-CM) improves data analysis accuracy.
Area of Science:
- Biostatistics
- Longitudinal Data Analysis
- Clinical Research Methodology
Background:
- Multivariate linear mixed models are standard for repeated measures but struggle with outliers and missing data.
- Existing methods may not adequately handle complex clinical datasets with censored and intermittent missing responses.
- Robust statistical modeling is crucial for accurate analysis of patient data in clinical studies.
Purpose of the Study:
- To develop a robust statistical model for jointly analyzing multiple, complex, repeated clinical measures.
- To extend the capabilities of multivariate linear mixed models by incorporating a multivariate contaminated normal distribution.
- To effectively handle outliers, censored data, and missing responses in longitudinal clinical studies.
Main Methods:
- The proposed multivariate contaminated normal linear mixed model with censored and missing responses (MCNLMM-CM) was developed.
- An expectation conditional maximization (ECM) algorithm was employed for parameter estimation with missing at random responses.
- Techniques for standard error approximation, data recovery, imputation, and outlier identification were provided.
Main Results:
- A simulation study demonstrated the superior finite-sample performance of the MCNLMM-CM compared to existing models.
- The model effectively handles minor outliers, censored measurements, and intermittent missing responses.
- Parameter estimators showed robust properties in the simulation.
Conclusions:
- The MCNLMM-CM offers a robust and effective approach for analyzing complex longitudinal clinical data.
- The methodology is well-suited for datasets with data quality issues like outliers and missingness.
- The model's application to Alzheimer's disease neuroimaging data highlights its practical utility.
Related Concept Videos
Censoring Survival Data
Mechanistic Models: Compartment Models in Individual and Population Analysis
Assumptions of Survival Analysis
Comparing the Survival Analysis of Two or More Groups
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

